4.6 Article

Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study

期刊

ADDICTION
卷 109, 期 2, 页码 262-272

出版社

WILEY
DOI: 10.1111/add.12370

关键词

ADHD; antisocial personality disorder; bipolar disorder; borderline personality disorder; comorbidity; depression; substance use disorder

资金

  1. Janssen Cilag
  2. Eli Lilly Company
  3. Shire
  4. Noaber Foundation
  5. Waterloo Foundation
  6. Augeo Foundation
  7. Fonds NutsOhra
  8. Norway, Bergen Clinics Foundation
  9. Bergen Clinics Foundation. Norway, Fredrikstad
  10. Sykehuset Ostfold HF
  11. Stockholm Centre for Dependency Disorders
  12. French Ministry of Health [2006-12]
  13. French National Research Agency PRA-CNRS-CHU-Bordeaux award [2008-10]
  14. Plan Nacional sobre Drogas, Ministerio de Sanidad y Politica Social [PND 0080/2011]
  15. Agencia de Salut Publica de Barcelona
  16. Departament de Salut, Government of Catalonia, Spain
  17. Swiss Foundation of Alcohol Research [209]
  18. European Union
  19. European Social Fund [TaMOP 4.2.1./B-09/1/KMR-2010-0003]
  20. Curtin University of Technology, Perth, Western Australia

向作者/读者索取更多资源

AimsTo determine comorbidity patterns in treatment-seeking substance use disorder (SUD) patients with and without adult attention deficit hyperactivity disorder (ADHD), with an emphasis on subgroups defined by ADHD subtype, taking into account differences related to gender and primary substance of abuse. DesignData were obtained from the cross-sectional International ADHD in Substance use disorder Prevalence (IASP) study. SettingForty-seven centres of SUD treatment in 10 countries. ParticipantsA total of 1205 treatment-seeking SUD patients. MeasurementsStructured diagnostic assessments were used for all disorders: presence of ADHD was assessed with the Conners' Adult ADHD Diagnostic Interview for DSM-IV (CAADID), the presence of antisocial personality disorder (ASPD), major depression (MD) and (hypo)manic episode (HME) was assessed with the Mini International Neuropsychiatric Interview-Plus (MINI Plus), and the presence of borderline personality disorder (BPD) was assessed with the Structured Clinical Interview for DSM-IV Axis II (SCID II). FindingsThe prevalence of DSM-IV adult ADHD in this SUD sample was 13.9%. ASPD [odds ratio (OR)=2.8, 95% confidence interval (CI)=1.8-4.2], BPD (OR=7.0, 95% CI=3.1-15.6 for alcohol; OR=3.4, 95% CI=1.8-6.4 for drugs), MD in patients with alcohol as primary substance of abuse (OR=4.1, 95% CI=2.1-7.8) and HME (OR=4.3, 95% CI=2.1-8.7) were all more prevalent in ADHD(+) compared with ADHD(-) patients (P<0.001). These results also indicate increased levels of BPD and MD for alcohol compared with drugs as primary substance of abuse. Comorbidity patterns differed between ADHD subtypes with increased MD in the inattentive and combined subtype (P<0.01), increased HME and ASPD in the hyperactive/impulsive (P<0.01) and combined subtypes (P<0.001) and increased BPD in all subtypes (P<0.001) compared with SUD patients without ADHD. Seventy-five per cent of ADHD patients had at least one additional comorbid disorder compared with 37% of SUD patients without ADHD. ConclusionsTreatment-seeking substance use disorder patients with attention deficit hyperactivity disorder are at a very high risk for additional externalizing disorders.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据